Dare Bioscience, Inc. Common Stock (DARE) is a publicly traded Healthcare sector company. As of July 27, 2026, DARE trades at $1.28 with a market cap of $19.17M and a P/E ratio of -1.07. DARE moved +1.59% today. Year to date, DARE is -34.69%; over the trailing twelve months it is -51.33%. Its 52-week range spans $1.16 to $9.19. Analyst consensus is buy with an average price target of $10.00. Rallies surfaces DARE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
2 analysts cover DARE: 0 strong buy, 2 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $10.00.
| Metric | Value |
|---|---|
| Price | $1.28 |
| Market Cap | $19.17M |
| P/E Ratio | -1.07 |
| EPS | $-1.20 |
| Dividend Yield | 0.00% |
| 52-Week High | $9.19 |
| 52-Week Low | $1.16 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $1.03M |
| Net Income | $-13.40M |
| Gross Margin | 71.29% |
2 analysts cover DARE: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $10.00.